How M.B.A. was paid
$2.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Vlad Vitoc, M.D. M.B.A.Chief Executive Officer and President | $612,333 | $334,813 | $1,124,480 | $13,006 | $2,084,632 |
| Jeffrey C. HimmelreichHead of Finance | $272,917 | $68,229 | $69,602 | $10,240 | $420,988 |
| Sergei GryaznovChief Scientific Officer | $478,500 | $213,813 | $562,240 | $12,741 | $1,267,294 |
What changed and why
- $2.1MCEO total compensation increased to $2,084,632 in fiscal 2025 from $1,360,441 in fiscal 2024.
- Board determined no bonuses will be payable to named executive officers for 2025 due to market conditions.
- Employment agreements were amended in February 2025 to increase base salaries and bonus percentages for executives.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.